Skip to main content
PMC home page
Gut logoLink to Gut
. 1984 Dec;25(12):1399–1413. doi: 10.1136/gut.25.12.1399

Prostaglandins and ulcerative colitis.

D S Rampton, C J Hawkey
PMCID: PMC1420195  PMID: 6150882

Full text

PDF
1399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archampong E. Q., Harris J., Clark C. G. The absorption and secretion of water and electrolytes across the healthy and the diseased human colonic mucosa measured in vitro. Gut. 1972 Nov;13(11):880–886. doi: 10.1136/gut.13.11.880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Azad Khan A. K., Piris J., Truelove S. C. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet. 1977 Oct 29;2(8044):892–895. doi: 10.1016/s0140-6736(77)90831-5. [DOI] [PubMed] [Google Scholar]
  3. Bennett A., Fleshler B. Prostaglandins and the gastrointestinal tract. Gastroenterology. 1970 Nov;59(5):790–800. [PubMed] [Google Scholar]
  4. Bennett A., Hensby C. N., Sanger G. J., Stamford I. F. Metabolites of arachidonic acid formed by human gastrointestinal tissues and their actions on the muscle layers. Br J Pharmacol. 1981 Oct;74(2):435–444. doi: 10.1111/j.1476-5381.1981.tb09989.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bennett A., Stamford I. F., Stockley H. L. Estimation and characterization of prostaglandins in the human gastrointestinal tract. Br J Pharmacol. 1977 Dec;61(4):579–586. doi: 10.1111/j.1476-5381.1977.tb07551.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bennett A., Tacca M. D., Stamford I. F., Zebro T. Prostaglandins from tumours of human large bowel. Br J Cancer. 1977 Jun;35(6):881–884. doi: 10.1038/bjc.1977.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Berry H., Swinson D., Jones J., Hamilton E. B. Indomethacin and naproxen suppositories in the treatment of rheumatoid arthritis. Ann Rheum Dis. 1978 Aug;37(4):370–372. doi: 10.1136/ard.37.4.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Beubler E., Juan H. Is the effect of diphenolic laxatives mediated via release of prostaglandin E? Experientia. 1978 Mar 15;34(3):386–387. doi: 10.1007/BF01923051. [DOI] [PubMed] [Google Scholar]
  9. Binder H. J. New modes for regulating intestinal ion transport. Gastroenterology. 1980 Mar;78(3):642–644. [PubMed] [Google Scholar]
  10. Bolton J. P., Palmer D., Cohen M. M. Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins. Am J Dig Dis. 1978 Apr;23(4):359–364. doi: 10.1007/BF01072421. [DOI] [PubMed] [Google Scholar]
  11. Boughton-Smith N. K., Hawkey C. J., Whittle B. J. Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa. Gut. 1983 Dec;24(12):1176–1182. doi: 10.1136/gut.24.12.1176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bukhave K., Rask-Madsen J. Saturation kinetics applied to in vitro effects of low prostaglandin E2 and F 2 alpha concentrations on ion transport across human jejunal mucosa. Gastroenterology. 1980 Jan;78(1):32–42. [PubMed] [Google Scholar]
  13. CONNELL A. M. The motility of the pelvic colon. II. Paradoxical motility in diarrhoea and constipation. Gut. 1962 Dec;3:342–348. doi: 10.1136/gut.3.4.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Campieri M., Lanfranchi G. A., Bazzocchi G., Brignola C., Benatti A., Boccia S., Labo' G. Prostaglandins, indomethacin, and ulcerative colitis. Gastroenterology. 1980 Jan;78(1):193–193. [PubMed] [Google Scholar]
  15. Cassidy M. M., Lightfoot F. G. Effects of prostaglandin E1, administered by gastric intubation, on mucus secretory patterns in rat small intestine. Adv Prostaglandin Thromboxane Res. 1980;8:1589–1593. [PubMed] [Google Scholar]
  16. Collier H. O., Francis A. A., McDonald-Gibson W. J., Saeed S. A. Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites. Prostaglandins. 1976 Feb;11(2):219–225. doi: 10.1016/0090-6980(76)90145-3. [DOI] [PubMed] [Google Scholar]
  17. DUTHIE H. L., WATTS J. M., DEDOMBAL F. T., GOLIGHER J. C. SERUM ELECTROLYTES AND COLONIC TRANSFER OF WATER AND ELECTROLYTES IN CHRONIC ULCERATIVE COLITIS. Gastroenterology. 1964 Nov;47:525–530. [PubMed] [Google Scholar]
  18. Dawson W., Boot J. R., Harvey J., Walker J. R. The pharmacology of benoxaprofen with particular to effects on lipoxygenase product formation. Eur J Rheumatol Inflamm. 1982;5(2):61–68. [PubMed] [Google Scholar]
  19. Day T. K. Intestinal perforation associated with osmotic slow release indomethacin capsules. Br Med J (Clin Res Ed) 1983 Dec 3;287(6406):1671–1672. doi: 10.1136/bmj.287.6406.1671-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Dharmsathaphorn K., Racusen L., Dobbins J. W. Effect of somatostatin on ion transport in the rat colon. J Clin Invest. 1980 Oct;66(4):813–820. doi: 10.1172/JCI109919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Edmonds C. J., Pilcher D. Electrical potential difference and sodium and potassium fluxes across rectal mucosa in ulcerative colitis. Gut. 1973 Oct;14(10):784–789. doi: 10.1136/gut.14.10.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Engineer D. M., Niederhauser U., Piper P. J., Sirois P. Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine. Br J Pharmacol. 1978 Jan;62(1):61–66. doi: 10.1111/j.1476-5381.1978.tb07006.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ferguson W. W., Edmonds A. W., Starling J. R., Wangensteen S. L. Protective effect of prostaglandin E 1 (PGE 1 ) on lysosomal enzyme release in serotonin-induced gastric ulceration. Ann Surg. 1973 Jun;177(6):648–654. doi: 10.1097/00000658-197306000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Flower R. J., Blackwell G. J. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature. 1979 Mar 29;278(5703):456–459. doi: 10.1038/278456a0. [DOI] [PubMed] [Google Scholar]
  25. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  26. Gallavan R. H., Jr, Jacobson E. D. Prostaglandins and the splanchnic circulation. Proc Soc Exp Biol Med. 1982 Sep;170(4):391–397. doi: 10.3181/00379727-170-41448. [DOI] [PubMed] [Google Scholar]
  27. Gilat T., Ratan J., Rosen P., Peled Y. Prostaglandins and ulcerative colitis. Gastroenterology. 1979 May;76(5 Pt 1):1083–1083. [PubMed] [Google Scholar]
  28. Goldin E., Rachmilewitz D. Prostanoids cytoprotection for maintaining remission in ulcerative colitis. Failure of 15(R), 15-methylprostaglandin E2. Dig Dis Sci. 1983 Sep;28(9):807–811. doi: 10.1007/BF01296903. [DOI] [PubMed] [Google Scholar]
  29. Gould S. R. Assay of prostaglandin-like substances in faeces and their measurement in ulcerative colitis. Prostaglandins. 1976 Mar;11(3):489–497. doi: 10.1016/0090-6980(76)90095-2. [DOI] [PubMed] [Google Scholar]
  30. Gould S. R., Brash A. R., Conolly M. E. Increased prostaglandin production in ulcerative colitis. Lancet. 1977 Jul 9;2(8028):98–98. doi: 10.1016/s0140-6736(77)90111-8. [DOI] [PubMed] [Google Scholar]
  31. Gould S. R., Brash A. R., Conolly M. E., Lennard-Jones J. E. Studies of prostaglandins and sulphasalazine in ulcerative colitis. Prostaglandins Med. 1981 Feb;6(2):165–182. doi: 10.1016/0161-4630(81)90088-4. [DOI] [PubMed] [Google Scholar]
  32. Gould S. R. Letter: Prostaglandins, ulcerative colitis, and sulphasalazine. Lancet. 1975 Nov 15;2(7942):988–988. doi: 10.1016/s0140-6736(75)90414-6. [DOI] [PubMed] [Google Scholar]
  33. Granger D. N., Richardson P. D., Kvietys P. R., Mortillaro N. A. Intestinal blood flow. Gastroenterology. 1980 Apr;78(4):837–863. [PubMed] [Google Scholar]
  34. Gullikson G. W., Sender M., Bass P. Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity. J Pharmacol Exp Ther. 1982 Feb;220(2):236–242. [PubMed] [Google Scholar]
  35. Hall R. I., Petty A. H., Cobden I., Lendrum R. Enteritis and colitis associated with mefenamic acid. Br Med J (Clin Res Ed) 1983 Oct 22;287(6400):1182–1182. doi: 10.1136/bmj.287.6400.1182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Hardcastle J., Hardcastle P. T., Redfern J. S. The effect of prostacyclin on intestinal ion transport in the rat. Life Sci. 1980 Jan 14;26(2):123–131. doi: 10.1016/0024-3205(80)90056-9. [DOI] [PubMed] [Google Scholar]
  37. Harris D. W., Smith P. R., Swan C. H. Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease. Gut. 1978 Oct;19(10):875–877. doi: 10.1136/gut.19.10.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Harris D. W., Swan C. H., Smith P. R. Venous prostaglandin-like activity in diarrhoeal states. Gut. 1978 Nov;19(11):1057–1058. doi: 10.1136/gut.19.11.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Harris J., Archampong E. Q., Clark C. G. The effect of salazopyrin on water and electrolyte transport in the human colon measured in vivo and in vitro. Gut. 1972 Oct;13(10):855–855. [PubMed] [Google Scholar]
  40. Harris J., Shields R. Absorption and secretion of water and electrolytes by the intact human colon in diffuse untreated proctocolitis. Gut. 1970 Jan;11(1):27–33. doi: 10.1136/gut.11.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Hawker P. C., McKay J. S., Turnberg L. A. Electrolyte transport across colonic mucosa from patients with inflammatory bowel disease. Gastroenterology. 1980 Sep;79(3):508–511. [PubMed] [Google Scholar]
  42. Hawkey C. J., Karmeli F., Rachmilewitz D. Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease. Gut. 1983 Oct;24(10):881–885. doi: 10.1136/gut.24.10.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Hawkey C. J., Lo Casto M. Inhibition of prostaglandin synthetase in human rectal mucosa. Gut. 1983 Mar;24(3):213–217. doi: 10.1136/gut.24.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Hawkey C. J., Rampton D. S. Benoxaprofen in the treatment of active ulcerative colitis. Prostaglandins Leukot Med. 1983 Apr;10(4):405–409. doi: 10.1016/0262-1746(83)90052-5. [DOI] [PubMed] [Google Scholar]
  45. Hawkey C. J., Truelove S. C. Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay. Gut. 1981 Mar;22(3):190–193. doi: 10.1136/gut.22.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Hawley C. J. Evidence that prednisolone is inhibitory to the cyclooxygenase activity of human rectal mucosa. Prostaglandins. 1982 Mar;23(3):397–409. doi: 10.1016/0090-6980(82)90085-5. [DOI] [PubMed] [Google Scholar]
  47. Hillier K., Mason P. J., Pacheco S., Smith C. L. Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro. Br J Pharmacol. 1982 May;76(1):157–161. doi: 10.1111/j.1476-5381.1982.tb09201.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Horton E. W., Main I. H., Thompson C. J., Wright P. M. Effect of orally administered prostaglandin E1 on gastric secretion and gastrointestinal motility in man. Gut. 1968 Dec;9(6):655–658. doi: 10.1136/gut.9.6.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Hoult J. R., Moore P. K., Marcus A. J., Watt J. On the effect of sulphasalazine on the prostaglandin system and the defective prostaglandin inactivation observed in experimental ulcerative colitis. Agents Actions Suppl. 1979;(4):232–244. [PubMed] [Google Scholar]
  50. Hoult J. R., Moore P. K. Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis. Br J Pharmacol. 1978 Sep;64(1):6–8. doi: 10.1111/j.1476-5381.1978.tb08633.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Hoult J. R., Page H. 5-Aminosalicylic acid, a co-factor for colonic prostacyclin synthesis? Lancet. 1981 Aug 1;2(8240):255–255. doi: 10.1016/s0140-6736(81)90502-x. [DOI] [PubMed] [Google Scholar]
  52. Hultén L., Lindhagen J., Lundgren O., Fasth S., Ahrén C. Regional intestinal blood flow in ulcerative colitis and Crohn's disease. Gastroenterology. 1977 Mar;72(3):388–396. [PubMed] [Google Scholar]
  53. Hunt R. H., Dilawari J. B., Misiewicz J. J. The effect of intravenous prostaglandin F2 alpha and E2 on the motility of the sigmoid colon. Gut. 1975 Jan;16(1):47–49. doi: 10.1136/gut.16.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Karim S. M., Filshie G. M. Therapeutic abortion using prostaglandin F2alpha. Lancet. 1970 Jan 24;1(7639):157–159. doi: 10.1016/s0140-6736(70)90402-2. [DOI] [PubMed] [Google Scholar]
  55. Karmali R. A. Review: prostaglandins and cancer. Prostaglandins Med. 1980 Jul;5(1):11–28. doi: 10.1016/0161-4630(80)90086-5. [DOI] [PubMed] [Google Scholar]
  56. Kelly J. P., Johnson M. C., Parker C. W. Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway. J Immunol. 1979 Apr;122(4):1563–1571. [PubMed] [Google Scholar]
  57. Kent T. H., Cardelli R. M., Stamler F. W. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol. 1969 Feb;54(2):237–249. [PMC free article] [PubMed] [Google Scholar]
  58. Kimberg D. V., Field M., Gershon E., Henderson A. Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of toxin. J Clin Invest. 1974 Mar;53(3):941–949. doi: 10.1172/JCI107635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Kimberg D. V., Field M., Johnson J., Henderson A., Gershon E. Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J Clin Invest. 1971 Jun;50(6):1218–1230. doi: 10.1172/JCI106599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Kimberg D. V. The ubiquitous prostaglandins and their role in ulcerative colitis. Gastroenterology. 1978 Oct;75(4):748–750. [PubMed] [Google Scholar]
  61. Kirsner J. B., Shorter R. G. Recent developments in "nonspecific" inflammatory bowel disease (first of two parts). N Engl J Med. 1982 Apr 1;306(13):775–785. doi: 10.1056/NEJM198204013061304. [DOI] [PubMed] [Google Scholar]
  62. Kuehl F. A., Jr, Humes J. L., Ham E. A., Egan R. W., Dougherty H. W. Inflammation: the role of peroxidase-derived products. Adv Prostaglandin Thromboxane Res. 1980;6:77–86. [PubMed] [Google Scholar]
  63. LaMont J. T., Ventola A. Stimulation of colonic glycoprotein synthesis by dibutyryl cyclic AMP and theophylline. Gastroenterology. 1977 Jan;72(1):82–86. [PubMed] [Google Scholar]
  64. Levy N., Gaspar E. Letter: Rectal bleeding and indomethacin suppositories. Lancet. 1975 Mar 8;1(7906):577–577. doi: 10.1016/s0140-6736(75)91600-1. [DOI] [PubMed] [Google Scholar]
  65. Lewis G. P. Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation. Br Med Bull. 1983 Jul;39(3):243–248. doi: 10.1093/oxfordjournals.bmb.a071827. [DOI] [PubMed] [Google Scholar]
  66. Ligumsky M., Karmeli F., Sharon P., Zor U., Cohen F., Rachmilewitz D. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology. 1981 Sep;81(3):444–449. [PubMed] [Google Scholar]
  67. Marnett L. J. Polycyclic aromatic hydrocarbon oxidation during prostaglandin biosynthesis. Life Sci. 1981 Aug 10;29(6):531–546. doi: 10.1016/0024-3205(81)90431-8. [DOI] [PubMed] [Google Scholar]
  68. Matuchansky C., Coutrot S. The role of prostaglandins in the study of intestinal water and electrolyte transport in man. Biomedicine. 1978 May-Jun;28(3):143–148. [PubMed] [Google Scholar]
  69. Mayhew J. W., Lombardi P. E., Fawaz K., Goldin B., Foster E. A., Goldberg M., Sepersky R., Kellum J. M., Gorbach S. L. Increased oxidation of a chemical carcinogen, benzo(a)pyrene, by colon tissue biopsy specimens from patients with ulcerative colitis. Gastroenterology. 1983 Aug;85(2):328–334. [PubMed] [Google Scholar]
  70. Metz S. A., McRae J. R., Robertson R. P. Prostaglandins as mediators of paraneoplastic syndromes: review and up-date. Metabolism. 1981 Mar;30(3):299–316. doi: 10.1016/0026-0495(81)90156-6. [DOI] [PubMed] [Google Scholar]
  71. Miller T. A., Jacobson E. D. Gastrointestinal cytoprotection by prostaglandins. Gut. 1979 Jan;20(1):75–87. doi: 10.1136/gut.20.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Milton-Thompson G. J., Cummings J. H., Newman A., Billings J. A., Misiewicz J. J. Colonic and small intestinal response to intravenous prostaglandin F2 alpha and E2 in man. Gut. 1975 Jan;16(1):42–46. doi: 10.1136/gut.16.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Misiewicz J. J., Waller S. L., Kiley N. Effect of oral prostaglandin E1 on intestinal transit in man. Lancet. 1969 Mar 29;1(7596):648–651. doi: 10.1016/s0140-6736(69)92012-1. [DOI] [PubMed] [Google Scholar]
  74. Musch M. W., Miller R. J., Field M., Siegel M. I. Stimulation of colonic secretion by lipoxygenase metabolites of arachidonic acid. Science. 1982 Sep 24;217(4566):1255–1256. doi: 10.1126/science.6810465. [DOI] [PubMed] [Google Scholar]
  75. Peskar B. M., Günter B., Peskar B. A. Prostaglandins and prostaglandin metabolites in human gastric juice. Prostaglandins. 1980 Aug;20(2):419–427. doi: 10.1016/s0090-6980(80)80059-1. [DOI] [PubMed] [Google Scholar]
  76. Peskar B. M., Holland A., Peskar B. A. Effect of carbenoxolone on prostaglandin synthesis and degradation. J Pharm Pharmacol. 1976 Feb;28(2):146–148. doi: 10.1111/j.2042-7158.1976.tb04113.x. [DOI] [PubMed] [Google Scholar]
  77. Prescott S. M., Majerus P. W. Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. J Biol Chem. 1983 Jan 25;258(2):764–769. [PubMed] [Google Scholar]
  78. Rachmilewitz D., Karmeli F., Selinger Z. Increased colonic adenylate cyclase activity in active ulcerative colitis. Gastroenterology. 1983 Jul;85(1):12–16. [PubMed] [Google Scholar]
  79. Rachmilewitz D., Ligumsky M., Haimovitz A., Treves A. J. Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel. Gastroenterology. 1982 Apr;82(4):673–679. [PubMed] [Google Scholar]
  80. Rachmilewitz D. Prostaglandins and diarrhea. Dig Dis Sci. 1980 Dec;25(12):897–899. doi: 10.1007/BF01308037. [DOI] [PubMed] [Google Scholar]
  81. Racusen L. C., Binder H. J. Effect of prostaglandin on ion transport across isolated colonic mucosa. Dig Dis Sci. 1980 Dec;25(12):900–904. doi: 10.1007/BF01308038. [DOI] [PubMed] [Google Scholar]
  82. Rampton D. S., Barton T. P. Are prostaglandins cytoprotective in the human large intestine? The effect of indomethacin on rectal mucosal function and prostaglandin E2 release in vivo. Agents Actions. 1984 Jun;14(5-6):715–718. doi: 10.1007/BF01978913. [DOI] [PubMed] [Google Scholar]
  83. Rampton D. S., Breuer N. F., Vaja S. G., Sladen G. E., Dowling R. H. Role of prostaglandins in bile salt-induced changes in rat colonic structure and function. Clin Sci (Lond) 1981 Nov;61(5):641–648. doi: 10.1042/cs0610641. [DOI] [PubMed] [Google Scholar]
  84. Rampton D. S., McNeil N. I., Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut. 1983 Mar;24(3):187–189. doi: 10.1136/gut.24.3.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Rampton D. S., Sladen G. E., Bhakoo K. K., Heinzelmann D. I., Youlten L. J. Rectal mucosal prostaglandin E release and electrolyte transport in ulcerative colitis. Adv Prostaglandin Thromboxane Res. 1980;8:1621–1625. [PubMed] [Google Scholar]
  86. Rampton D. S., Sladen G. E. Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment. Prostaglandins. 1981 Mar;21(3):417–425. doi: 10.1016/0090-6980(81)90087-3. [DOI] [PubMed] [Google Scholar]
  87. Rampton D. S., Sladen G. E. Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs. Postgrad Med J. 1981 May;57(667):297–299. doi: 10.1136/pgmj.57.667.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Rampton D. S., Sladen G. E. The effect of sulphasalazine withdrawal on rectal mucosal function and prostaglandin E2 release in inactive ulcerative colitis. Scand J Gastroenterol. 1981;16(1):157–159. [PubMed] [Google Scholar]
  89. Rampton D. S., Sladen G. E., Youlten L. J. Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis. Gut. 1980 Jul;21(7):591–596. doi: 10.1136/gut.21.7.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Reinhart W. H., Müller O., Halter F. Influence of long-term 16,16-dimethyl prostaglandin E2 treatment on the rat gastrointestinal mucosa. Gastroenterology. 1983 Nov;85(5):1003–1010. [PubMed] [Google Scholar]
  91. Robert A. Cytoprotection by prostaglandins. Gastroenterology. 1979 Oct;77(4 Pt 1):761–767. [PubMed] [Google Scholar]
  92. Schiessel R., Matthews J., Barzilai A., Merhav A., Silen W. PGE2 stimulates gastric chloride transport: possible key to cytoprotection. Nature. 1980 Feb 14;283(5748):671–673. doi: 10.1038/283671a0. [DOI] [PubMed] [Google Scholar]
  93. Sharon P., Ligumsky M., Rachmilewitz D., Zor U. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology. 1978 Oct;75(4):638–640. [PubMed] [Google Scholar]
  94. Sharon P., Stenson W. F. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology. 1984 Mar;86(3):453–460. [PubMed] [Google Scholar]
  95. Simon B., Kather H. Human colonic adenylate cyclase. Stimulation of enzyme activity by vasoactive intestinal peptide and various prostaglandins via distinct receptor sites. Digestion. 1980;20(1):62–67. doi: 10.1159/000198415. [DOI] [PubMed] [Google Scholar]
  96. Sircar J. C., Schwender C. F., Carethers M. E. Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis. Biochem Pharmacol. 1983 Jan 1;32(1):170–172. doi: 10.1016/0006-2952(83)90673-1. [DOI] [PubMed] [Google Scholar]
  97. Smith P. R., Dawson D. J., Swan C. H. Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone. Gut. 1979 Sep;20(9):802–805. doi: 10.1136/gut.20.9.802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Stenson W. F., Lobos E. Inhibition of platelet thromboxane synthetase by sulfasalazine. Biochem Pharmacol. 1983 Jul 15;32(14):2205–2209. doi: 10.1016/0006-2952(83)90227-7. [DOI] [PubMed] [Google Scholar]
  99. Stenson W. F., Lobos E. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J Clin Invest. 1982 Feb;69(2):494–497. doi: 10.1172/JCI110474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Steven K., Lange P., Bukhave K., Rask-Madsen J. Prostaglandin E2-mediated secretory diarrhea in villous adenoma of rectum: effect of treatment with indomethacin. Gastroenterology. 1981 Jun;80(6):1562–1566. [PubMed] [Google Scholar]
  101. Stewart T. H., Hetenyi C., Rowsell H., Orizaga M. Ulcerative enterocolitis in dogs induced by drugs. J Pathol. 1980 Aug;131(4):363–378. doi: 10.1002/path.1711310408. [DOI] [PubMed] [Google Scholar]
  102. Suzuki T., Vogt W. Prostaglandine in einem Darmstoffpräparat aus Froschdarm. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1965 Nov 4;252(1):68–78. [PubMed] [Google Scholar]
  103. Taub M., Coyne M. J., Bonorris G. G., Chung A., Coyne B., Schoenfield L. J. Inhibition by propranolol of bile acid- and PGE1-stimulated camp and intestinal secretion. Am J Gastroenterol. 1978 Aug;70(2):129–135. [PubMed] [Google Scholar]
  104. Vane J. R. Prostaglandins as mediators of inflammation. Adv Prostaglandin Thromboxane Res. 1976;2:791–801. [PubMed] [Google Scholar]
  105. Waller S. L. Prostaglandins and the gastrointestinal tract. Gut. 1973 May;14(5):402–417. doi: 10.1136/gut.14.5.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Wright V., Hopkins R. A note on indomethacin suppositories in rheumatic conditions. Rheumatol Rehabil. 1979 Aug;18(3):186–187. doi: 10.1093/rheumatology/18.3.186. [DOI] [PubMed] [Google Scholar]
  107. Zifroni A., Treves A. J., Sachar D. B., Rachmilewitz D. Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. Gut. 1983 Jul;24(7):659–664. doi: 10.1136/gut.24.7.659. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES